- Filed
- May 8, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · May 8, 2024 | 969.83K sh |
| Long Term Debt | Q3 2024 · Mar 31, 2024 | $34.61K |
| Cash And Equivalents | Q3 2024 · Mar 31, 2024 | $84.19K |
| Cash And Equivalents | Q3 2024 · Jun 30, 2023 | $11.3K |
| Current Liabilities | Q3 2024 · Mar 31, 2024 | $154.87K |
| Current Liabilities | Q3 2024 · Jun 30, 2023 | $408.17K |
| Total Liabilities | Q3 2024 · Mar 31, 2024 | $503.54K |
| Total Liabilities | Q3 2024 · Jun 30, 2023 | $806.01K |
| Current Assets | Q3 2024 · Mar 31, 2024 | $783.38K |
| Current Assets | Q3 2024 · Jun 30, 2023 | $1.09M |
| Total Assets | Q3 2024 · Mar 31, 2024 | $1.34M |
| Total Assets | Q3 2024 · Jun 30, 2023 | $1.7M |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 2M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 2M sh |
| Capex | Q3 2024 · Mar 31, 2023 | $60.69K |
| Operating Cash Flow | Q3 2024 · Mar 31, 2023 | $319.23K |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | $968.09K |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $1.05M |
| Stockholders Equity | Q3 2024 · Jun 30, 2022 | $739.26K |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | −$0.12 |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | $0.11 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | −$0.12 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | $0.14 |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $107.59K |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $454.13K |
| Net Income | Q3 2024 · Mar 31, 2023 | −$83.02K |
| Net Income | Q3 2024 · Mar 31, 2023 | $228.82K |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$83.23K |
| Operating Income | Q3 2024 · Mar 31, 2023 | $234.84K |
| Gross Profit | Q3 2024 · Mar 31, 2023 | $94.34K |
| Gross Profit | Q3 2024 · Mar 31, 2023 | $967.48K |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $413.58K |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $1.98M |